ARISAPH PHARMACEUTICALS, INC.
ARI-3037MO, a synthetic nicotinic acid analog small-molecule therapeutic for nonalcoholic steatohepatitis (NASH)
- Sector
- Biotech
- Headquarters
- BOSTON, MA
- Latest Form D
- $10M, Nov 2013
- Total capital
- $11M
- Federal grants
- $1M
- 2 awards · 2015
- Rank in peer group#290 of 326
- Private capital raised
- $10M
- 1 Form D · last Nov 2013
- 156 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 4 pending · first 2015
- Rank in peer group#80 of 326
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · A Safe and Tolerable Niacin Analog for Treatment of Nonalcoholic Steatohepatitis$499K
- Federal grantHealth and Human S · Phase II · A FAP-Activated Proteasome Inhibitor for Killing Solid Tumors$532K
- Private capital raisedForm D · SEC · 1st filing$10M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 326 peers
Line = medianBiotech · Molecule
- Federal grantsBelow median
- Granted patents#80 · top 25%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- William BachovchinResearcherExecutive Officer, DirectorLinked by 1 patent
- Claude BenedictResearcherExecutive OfficerLinked by $499K in grants as PI
- Antonio GottoDirectorNamed in SEC Form D filings
- Christopher KiritsyExecutive Officer, DirectorNamed in SEC Form D filings
- Joseph SuarezExecutive OfficerNamed in SEC Form D filings
- Kevin FerroDirectorNamed in SEC Form D filings
Show all 12 people
- Madias NicolaosDirectorNamed in SEC Form D filings
- Michael JaharisDirectorNamed in SEC Form D filings
- Rex RotenDirectorNamed in SEC Form D filings
- Robert BaldiniDirectorNamed in SEC Form D filings
- Steven JaharisDirectorNamed in SEC Form D filings
- Thomas KoestlerDirectorNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 5- PendingNiacin Mimetics, And Methods Of Use ThereofUSPTOApplication 14840887
- GrantedNiacin Mimetics, and Methods of Use ThereofUSPTOUS 9,212,142
- PendingNiacin Mimetics, and Methods of Use ThereofUSPTOApplication 14566343
Show all 5 patent records
- Niacin Mimetics, And Methods Of Use ThereofFeb 4, 2016 · Application 14840887Pending
- Niacin Mimetics, and Methods of Use ThereofDec 15, 2015 · US 9,212,142Granted
- Niacin Mimetics, and Methods of Use ThereofApr 2, 2015 · Application 14566343Pending
- Niacin Mimetics, And Methods Of Use ThereofApplication PCTUS2011041869Pending
- Niacin Mimetics, And Methods Of Use ThereofApplication PCTUS2011041878Pending
Related companies, and why
- QUANTUMBIO INCSimilar federal contract value in Biotech · null in contracts
- CANCURE LLCSimilar federal contract value in Biotech · null in contracts
- PETAOMICS, INC.Similar federal contract value in Biotech · null in contracts
- DNATRIX INCSimilar federal contract value in Biotech · null in contracts
- PROTAGONIST THERAPEUTICS, INC.Similar federal contract value in Biotech · null in contracts
- TATEVA THERAPEUTICS INC.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .